Deborah Moon
Corneal and Contact Management · Plano, TXNPI 1902972177
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 35 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Alcon at 25.4% of the total. Reporting peaked in 2023 at $314 and has fallen 65.8% since, to $107 in 2025. That places this record below the midpoint for corneal and contact management clinicians in TX, where the typical reported total is $1,160.
Across 35 payments — averaging $26.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$240
- Johnson & Johnson Vision Care, Inc.$225
- Optos, Inc.$184
- Coopervision Inc.$130
- Bausch & Lomb, A Division Of Bausch Health US, LLC$61
- Bausch & Lomb Americas Inc.$47
- plus $57 from 2 others
What the payments were for
- Food & beverage$942100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 7 | $240 |
| Johnson & Johnson Vision Care, Inc. | 11 | $225 |
| Optos, Inc. | 3 | $184 |
| Coopervision Inc. | 7 | $130 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $61 |
| Bausch & Lomb Americas Inc. | 2 | $47 |
| ABB Con-cise Optical Group LLC | 1 | $33 |
| Dompe US, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TOTAL30$139
How this compares
$942 in reported general payments places this provider in the 45th percentile of 103 corneal and contact management providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 17 | $6,915 |
| CombiganBrimonidine Tartrate/Timolol | 14 | $4,219 |
| Brimonidine Tartrate | 12 | $1,033 |
| Prednisolone Acetate | 22 | $620 |
| Latanoprost | 67 | $417 |
| Doxycycline Hyclate | 16 | $171 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 15 | $164 |
| Timolol Maleate | 20 | $95 |
Paid to pharmacies, not to this prescriber.
Other corneal and contact management in Plano
- Darlene JonesPlano$9K
- Danny MalonePlano$7K
- James WilliamsPlano$6K
- Hyejon KoPlano$3K
- Maurice WilsonConroe$362K
- Roberto SaenzSan Antonio$171K
- Fariba ParmerGrapevine$26K
- Vissett SunHouston$13K
- Napoleon LoveroHouston$12K
- Sairah MalikHouston$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.